ENVERIC BIOSCIENCES INC's ticker is and the CUSIP is 29405E208. A total of 15 filers reported holding ENVERIC BIOSCIENCES INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $339,184 | +0.2% | 146,833 | +46.2% | 0.09% | -6.2% |
| Q2 2023 | $338,446 | +40.9% | 100,429 | -29.8% | 0.10% | +29.3% |
| Q1 2023 | $240,267 | +0.8% | 143,016 | +23.0% | 0.08% | +11.9% |
| Q4 2022 | $238,405 | -28.0% | 116,295 | +48.4% | 0.07% | -24.7% |
| Q3 2022 | $331,000 | +23.5% | 78,354 | -93.7% | 0.09% | +18.7% |
| Q2 2022 | $268,000 | – | 1,252,390 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AdvisorShares Investments LLC | 100,429 | $338,446 | 0.10% |
| Tower Research Capital LLC (TRC) | 8,327 | $28,062 | 0.00% |
| UBS Group AG | 54 | $182 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 101 | $340 | 0.00% |
| WELLS FARGO & COMPANY/MN | 30 | $101 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 273 | $920 | 0.00% |
| MORGAN STANLEY | 1 | $3 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 4,559 | $15 | 0.00% |
| NATIONAL BANK OF CANADA /FI/ | 70 | $232 | 0.00% |